BMCM
JNJ icon

Bryn Mawr Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bryn Mawr Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.5M Sell
104,464
-6,215
-6% -$1.45M 1.24% 13
2025
Q4 		$22.9M Sell
110,679
-1,647
-1% -$326K 1.1% 18
2025
Q3 		$20.8M Sell
112,326
-1,213
-1% -$208K 1.03% 18
2025
Q2 		$17.3M Sell
113,539
-1,177
-1% -$181K 0.95% 19
2025
Q1 		$19M Sell
114,716
-14,322
-11% -$2.24M 1.14% 16
2024
Q4 		$18.7M Sell
129,038
-3,316
-3% -$514K 1.01% 18
2024
Q3 		$21.4M Sell
132,354
-121
-0.1% -$19.3K 1.16% 18
2024
Q2 		$19.4M Buy
132,475
+7,747
+6% +$1.15M 1.07% 18
2024
Q1 		$20.8M Sell
124,728
-8,738
-7% -$1.39M 1.18% 16
2023
Q4 		$20.9M Sell
133,466
-13,764
-9% -$2.11M 1.3% 14
2023
Q3 		$22.9M Buy
147,230
+103,114
+234% +$17M 1.5% 15
2023
Q2 		$7.3M Sell
44,116
-2,007
-4% -$324K 0.69% 40
2023
Q1 		$7.15M Sell
46,123
-592
-1% -$95.6K 0.75% 36
2022
Q4 		$8.25M Buy
46,715
+25,645
+122% +$4.43M 0.89% 31
2022
Q3 		$3.44M Sell
21,070
-84
-0.4% -$14.2K 1.22% 14
2022
Q2 		$3.75M Sell
21,154
-736
-3% -$131K 1.24% 13
2022
Q1 		$3.88M Buy
21,890
+13,043
+147% +$2.22M 1.08% 14
2021
Q4 		$1.51M Buy
8,847
+262
+3% +$42.9K 0.57% 33
2021
Q3 		$1.39M Sell
8,585
-1,251
-13% -$213K 0.63% 32
2021
Q2 		$1.62M Buy
9,836
+1,062
+12% +$176K 0.73% 31
2021
Q1 		$1.44M Buy
8,774
+180
+2% +$29.1K 0.71% 31
2020
Q4 		$1.35M Buy
8,594
+300
+4% +$44.3K 0.67% 31
2020
Q3 		$1.24M Sell
8,294
-44
-0.5% -$6.51K 0.72% 25
2020
Q2 		$1.17M Sell
8,338
-117
-1% -$17.1K 0.74% 24
2020
Q1 		$1.11M Buy
8,455
+276
+3% +$39.2K 0.75% 23
2019
Q4 		$1.19M Buy
8,179
+200
+3% +$27.1K 0.87% 23
2019
Q3 		$1.03M Sell
7,979
-1,000
-11% -$132K 0.86% 22
2019
Q2 		$1.25M Buy
8,979
+1,146
+15% +$159K 1.06% 21
2019
Q1 		$1.09M Sell
7,833
-6,131
-44% -$821K 0.99% 20
2018
Q4 		$1.8M Sell
13,964
-3,970
-22% -$554K 1.64% 11
2018
Q3 		$2.48M Buy
17,934
+109
+0.6% +$14.5K 2.08% 8
2018
Q2 		$2.16M Sell
17,825
-183
-1% -$22.8K 1.9% 10
2018
Q1 		$2.31M Buy
18,008
+485
+3% +$65.6K 2.1% 9
2017
Q4 		$2.28M Hold
17,523
– – 2.99% 7
2017
Q3 		$2.28M Buy
17,523
+364
+2% +$48.3K 2.37% 8
2017
Q2 		$2.27M Sell
17,159
-1,338
-7% -$171K 2.56% 8
2017
Q1 		$2.3M Sell
18,497
-8,555
-32% -$1.02M 2.37% 7
2016
Q4 		$3.12M Buy
+27,052
New +$3.12M 3.18% 6

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bryn Mawr Capital Management's JNJ Position: Q1 2026 in Review

Bryn Mawr Capital Management reduced its Johnson & Johnson (JNJ) stake by 5.6% in Q1 2026, selling an estimated $1.45M and leaving 104,464 shares worth $25.5M. The position accounts for 1.24% of the portfolio, ranked #13.

Bryn Mawr Capital Management first reported a position in JNJ in Q4 2016 and has held it in 38 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bryn Mawr Capital Management held 104,464 shares of Johnson & Johnson worth $25.5M as of Q1 2026.
  • Bryn Mawr Capital Management sold 6,215 Johnson & Johnson shares in Q1 2026, an estimated $1.45M.
  • Johnson & Johnson made up 1.24% of Bryn Mawr Capital Management's portfolio in Q1 2026, its #13 holding.
  • Bryn Mawr Capital Management first reported a position in Johnson & Johnson in Q4 2016 and has held it in 38 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2026, filed 4 May 2026.